Dioscorea

Dioscorea (Wild Yam & Yam Genus): A Comprehensive Reference

1. Identity and Botanical Classification

Dioscorea is a large genus of flowering plants in the family Dioscoreaceae. Dioscorea is a genus of over 600 species of flowering plants in the family Dioscoreaceae, native throughout the tropical and warm temperate regions of the world. They are monocotyledonous, herbaceous, vine or climbing plants of high economic value due to their diversity of uses. The genus consists of approximately 600 species distributed worldwide and spread to both temperate and tropical regions, such as Asia, South Africa, and North America. By the end of the 2010s, more than 60 countries had cultivated approximately ten species of this genus on a large scale.

The species most commonly encountered in dietary supplement and herbal medicine contexts include:

• Dioscorea villosa L. — North American wild yam. Common names include wild yam, Atlantic yam, common wild yam, wild yam-root, yellow yam, colic root, and rheumatism root. It is a twining vine native to the central southeastern US and found less frequently in the Appalachian region.
• Dioscorea polystachya Turcz. (syn. D. oppositifolia, D. opposita) — Chinese yam, known in Traditional Chinese Medicine (TCM) as Shan Yao (山药). Chinese yam, also known as Dioscorea opposita or Shan Yao in Pinyin, has long been used as a congenital and acquired tonic, earning it the name "fairy food."
• Dioscorea alata L. — Water yam or purple yam, widely cultivated for food across tropical Asia and the Pacific.
• Dioscorea bulbifera L. — Air yam or bitter yam. Also known as aerial yam, bitter yam, cheeky yam, potato yam and parsnip yam, it is a traditional medicinal plant native to Asia, Northern Australia, America and tropical Africa.
• Dioscorea zingiberensis — Ginger yam, a commercially significant source of diosgenin. Among tested plant samples, diosgenin was found in D. zingiberensis, D. septemloba, D. collettii and Heterosmilax yunnanensis. Research demonstrated that D. zingiberensis is an important resource for diosgenin harvesting.

There are an estimated 600 species of yam in the genus Dioscorea. Many of them are wild species that flourish in damp woodlands and thickets, and not all of them contain the medicinally active part, diosgenin. Only about 12 of the 600 species are considered edible.

Parts Used and Common Preparations

The part of the plant used is the root and rhizome. In the supplement and herbal trade, Dioscorea is encountered in numerous forms. Wild yam is usually found as a liquid extract, dried herb, powder, capsule, and tablet. The liquid can also be used to make tea, and creams are available. A manufacturing process for standardized extract involves cut up and ground rhizomes combined with an eluant (e.g., oleyl alcohol), the plant material precipitated with addition of a miscible solvent, washed, and redissolved in the original eluant. Topical creams containing wild yam extract are heavily marketed for menopausal and hormonal support applications. Popular specifications of wild yam root extract include 6% diosgenin, 10% diosgenin, 16% diosgenin, 95% diosgenin, 98% diosgenin, and ratio extracts of 4:1 and 10:1.

2. Traditional and Historical Use

North America — Native American and Eclectic Medicine

Wild yams have been used historically by the Meskwaki primarily to soothe labor pains; however, there are records of physicians using the root in an attempt to cure various respiratory issues, as well as rheumatism and morning sickness. In the 18th and 19th centuries, herbalists used wild yam (Dioscorea villosa) to treat menstrual cramps and problems related to childbirth, as well as for upset stomach and coughs. Wild yam was popularized by the Eclectic medical movement in the 19th century for its supposed antispasmodic properties and was therefore prescribed for biliary colic and spasm of the bowel. It was also promoted for the relief of nausea in pregnancy and for amenorrhea and dysmenorrhea.

Traditional Chinese Medicine

The earliest documented mention of Chinese yam appears in the Shen Nong Ben Cao Jing, an ancient pharmacopoeia that dates back over 2,000 years. This text highlights its significance as a food source and medicinal herb, emphasizing its role in promoting health and vitality. During the Ming Dynasty, the famous herbalist Li Shizhen further documented Shan Yao in his work, Ben Cao Gang Mu, where he noted its effectiveness in treating various ailments such as indigestion and diabetes.

Shan Yao belongs to the category of Qi tonics in the Chinese Materia Medica and is one of the most important and widely prescribed herbs in traditional Chinese medicine. It is used in Chinese herbal medicine both as a component of classical herbal formulas and as a significant individual herb in tailored prescriptions. In TCM its nature is characterised as sweet, slightly astringent, and neutral, and it is said to enter the Spleen, Lung, and Kidney channels. Actions include tonifying spleen, stomach, Lung, and kidney Qi and Yin; slightly controlling body fluids; and benefiting both the Yin and the Yang of the Lungs and kidneys.

The Tang Ye Ben Cao (Materia Medica of Decoctions), published in 1289 and written by Wang Haogu, documents that it can tonify middle-Jiao and Qi, replenish Qi, nourish blood, and invigorate the spleen. Shanyao was originally called Shuyu in classical Chinese texts, but its designation was changed to Shanyao when similar components in the names of two Tang and Song dynasty emperors rendered the common use of the characters Shu and Yu taboo. The name Shuyu literally translates as "Giant Tuber that Cures Everything" or "Gigantic Root that Nourishes Reserves."

African, Indian, and Other Traditions

The first report of Dioscorea bulbifera L. in the world was recorded in the earliest known pharmacopoeia "Tang Bencao" (657–659 A.D.). It is most widely used in the African, Chinese, and Indian systems of traditional medicine. Approximately 30 Dioscorea species have a rich history of traditional medicinal use in ancient civilizations. These include treatment of diseases and conditions such as respiratory illnesses, rheumatism, diabetes, diarrhea, and dysentery.

Several species of Dioscorea retain a prominent role in traditional medication to address a variety of disorders, as the root syrup of Dioscorea species is utilized to ease labour pain, and physicians also suggest it to people who suffer from colic discomfort, rheumatism, asthma, and stomach complaints. In India, specific species have documented regional uses: D. bulbifera L. is used against tuberculosis, and tubers of D. oppositifolia L. are used in the treatment of swellings, scorpion stings, and snake bites.

Although poisonous in some forms, some species are used as food (due to the starch, vitamin, and amino acid content in their tubers or rhizomes), to catch fish, to poison arrows, as insecticides, pediculicides, soap (shampoos), or ornamental, as well as in the traditional medicine of different cultures.

Traditional Preparations

Tubers are mostly soaked overnight in water or left overnight in a stream and subjected to successive boiling to remove the bitterness. In TCM, rhizomes are prepared either raw or dry-fried. Raw preparation is used to tonify the Yin, while dry-frying strengthens the spleen. The Chinese pharmacopoeia has prescribed Dioscorea rhizome specifically: in the Chinese pharmacopoeia, the medicinal uses of Dioscorea rhizome are prescribed for indigestion, anorexia, diarrhea, and diabetes.

3. Key Constituents and Active Compounds

The phytochemical profile of Dioscorea species is broad and varies considerably by species, geographic origin, and preparation. Dioscorea contains a wide range of plant phytochemicals, such as steroids, flavonoids, terpenoids, amino acids, and polysaccharides, among others, which exhibit diverse biological activities.

Steroidal Saponins and Diosgenin

The saponins from yam species have been used in industries for making steroid drugs. Over 50 steroid saponins of furostan-, spirostan-, and pregnane-type skeletons have been reported to be the major physiologically active constituents from various Dioscorea species. The most important single compound is diosgenin. Diosgenin is a well-known steroid sapogenin derived from plants and has been used as a starting material for production of steroidal hormones.

In terms of characterised saponins specifically from D. villosa: six saponins have been reported from wild species of yam native to North America, D. villosa, such as protodioscin, methyl protodioscin, parrisaponin, dioscin, pro-genin III (prosapogenin A of dioscin), and proge-nin II. Four major and three minor steroidal saponins from D. villosa have been identified using 2D NMR spectroscopy. The major saponins are two furanostane types, methyl parvifloside and protodeltonin, as well as two spirostane types, deltonin and glucosidodeltonin (zingiberensis I), and the minor saponins included methylprotodioscin, dioscin, and prosapogenin A of diosgenin.

The extract contains glycoside and steroidal saponins (≤0.4%), diosgenin (≤3.5%), alkaloids, tannins, phytosterols, and starch. In addition to diosgenin, D. villosa contains diarylheptanoids: 14 diarylheptanoids, including five new compounds with a tetrahydropyrano core skeleton, have been isolated.

Dioscorin (Storage Protein)

Dioscorin is a storage protein of yam species which acts as a trypsin inhibitor, carbonic anhydrase, antioxidant, immunomodulator, and hypertension inhibitor. Dioscorin accounts for over 90% of the extractable proteins in yam. Dioscorin has also been identified as an angiotensin-converting enzyme (ACE) inhibitor, suggesting its potential role in hypertension management. Dioscorin isolated from D. alata functions as a Toll-like receptor 4 (TLR4) activator and an inducer of cytokine expression in macrophages through the TLR4-signaling pathway, thereby stimulating both innate and adaptive immune responses.

Allantoin

Allantoin and dioscin are well-known active constituents from tubers of Dioscorea species. Six cultivars (D. alata, D. bulbifera, D. dumetorum, D. cayenensis, D. esculenta, and D. rotundata) have been detected for allantoin content, ranging from 0.23 to 22.35 mg/g DW. Allantoin has been identified as a key active compound responsible for antidiabetic effects through inhibition of alpha-amylase and alpha-glucosidase activity.

Polysaccharides

Dioscorea has many superior characteristics in the rhizome such as high viscosity and high contents of viscous polysaccharide comprising carbohydrate, mannose, arabinose, glucose, galactose, xylose, and rhamnose, starch, protein, vitamins, and minerals. The most meaningful bioactive compounds found in yam products include dietary fibers (e.g., resistant starch), steroidal sapogenins (e.g., diosgenin, methyl protodioscin), storage protein dioscorin, and polyphenols (e.g., total flavonoids, anthocyanins), the latter of which have been mostly found in purple yam.

Other Constituents

Yam tuber contains a variety of nutritional and functional ingredients, including starch, fiber, protein, polysaccharides, sapogenins, dioscorin, allantoin, flavonoids, polyphenols, and other active compounds. The full phytochemical profile also encompasses: protodioscin, methylprotodioscin, dioscine, prosapogenin, epiafzelechin glucopyranoside, saponin glycosides, steroidal saponins, diosgenin, alkaloids, tannins, and phytoestrogen-like constituents.

4. Mechanisms of Action

Diosgenin: Core Pharmacological Mechanisms

Diosgenin has shown a vast range of pharmacological activities in preclinical studies. It exhibits anticancer, cardiovascular protective, anti-diabetes, neuroprotective, immunomodulatory, estrogenic, and skin protective effects, mainly by inducing apoptosis, suppressing malignant transformation, decreasing oxidative stress, preventing inflammatory events, promoting cellular differentiation/proliferation, and regulating T-cell immune response.

Anti-inflammatory mechanisms: Diosgenin significantly reduces the secretion of different inflammatory factors including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 via upregulation of glucocorticoid receptors, secretory leukocyte protease inhibitor, glucocorticoid-induced leucine zipper, mitogen-activated protein kinases (MAPK) phosphatase 1, and downregulation of heat shock proteins (HSP70). Its anti-inflammatory activity is through inhibiting production of pro-inflammatory cytokines, enzymes, and adhesion molecules.

Estrogenic/steroidogenic mechanisms: Diosgenin drives cellular growth/differentiation through the estrogen receptor (ER) cascade and transcriptional factor PPARγ. However, a critical distinction must be made: diosgenin can be converted to steroid hormones by industrial processes, but cannot be biochemically transformed into steroid hormones by the human body.

Antidiabetic mechanisms: Mechanisms of action attributed to diosgenin in ameliorating experimentally induced diabetes include restoration of pancreatic β-cells in streptozotocin (STZ)-induced diabetic rats and T2 diabetic rats, down-regulation of enzymes involved in hepatic gluconeogenesis and glucose export, upregulation of hepatic glucokinase, and increase in the amounts of hepatoprotective and antioxidant enzymes. Studies also explore the modulation of adipose tissue function by diosgenin, which plays a key role in maintaining glycemic control by promoting adipocyte differentiation and inhibiting expressions of several molecular candidates associated with inflammation in 3T3-L1 cells.

Cardiovascular mechanisms: Diosgenin treatment significantly enhanced the expression of ATP-binding cassette transporter A1 (ABCA1) protein without any effect on liver X receptor α levels. Additionally, diosgenin treatment inhibits aortic atherosclerosis progression via downregulation of miR-19b proteins in THP-1 macrophages/MPM-derived foam cells. An important effect of the antioxidant diosgenin is its potential interest in the protection of cardiac cells from hypoxia-reoxygenation injury, which can be mediated by ATP-sensitive potassium channels and through modulation of cell prodeath (Bax) and cell prosurvival (Bcl2, heme oxygenase 1, and Akt) molecules.

Apoptosis and anticancer mechanisms: Diosgenin interferes with cell death pathways and their regulators to induce apoptosis. It antagonizes tumor metastasis by modulating epithelial-mesenchymal transition and actin cytoskeleton to change cellular motility, suppressing degradation of matrix barrier. Additionally, diosgenin improves antioxidant status and inhibits lipid peroxidation.

Bone-protective mechanisms: Recent studies indicated that diosgenin may protect against bone loss, namely, in experimental models of senescence, menopause, and retinoic acid-induced osteoporosis. However the mechanism of action is still not clear but can be associated with a modulation on the receptor activator of NF-kB ligand/osteoprotegerin ratio.

Important Caveat on In Vivo Conversion

A widespread misconception in commercial marketing is that diosgenin converts to progesterone or DHEA in the human body. The scientific evidence unambiguously refutes this claim. The wild yam contains diosgenin, a steroid that can be used to synthesize various hormones — estrogen, DHEA, and progesterone — in the laboratory. Yet while a small number of animal studies have demonstrated in vivo synthesis and hormone surge, studies in humans have not successfully replicated this process. Ingesting the yam extract has not been found to increase DHEA levels in humans.

5. Scientific Evidence by Area of Use

5.1 Menopausal Symptoms

Evidence level: Predominantly negative; limited human trials.

This is the most heavily researched clinical area for D. villosa. The key controlled human trial is a double-blind, placebo-controlled, crossover study of wild yam cream in menopausal women: a double-blind, placebo-controlled, cross-over study of the effects of a wild yam cream was conducted in 23 healthy women suffering from troublesome symptoms of the menopause. After a 4-week baseline period, each woman was given active cream and matching placebo for 3 months in random order. Diaries were completed over the baseline period and for 1 week each month thereafter, and blood and saliva samples were collected at baseline and at 3 and 6 months, for measurement of lipids and hormones. This randomized, double-blind, placebo-controlled trial evaluated daily topical application of D. villosa extract in menopausal women, finding no change in serum estrogen or progesterone, no effect on symptoms, and no effect on lipids, weight, or blood pressure.

A separate uncontrolled study evaluated dietary yam consumption: one uncontrolled clinical study evaluated the effect of consuming 390 g of yam over 30 days and found increases in serum estrone and sex hormone-binding globulin, but not in estradiol. This was a one-arm, pre-post design with a sweet potato control group (n = 19 for 41 days), limiting the interpretability of results.

A standardized, evidence-based rating system showed poor efficacy scores for the wild yam, indicating fair scientific evidence against its use for alleviating menopausal symptoms. Research into protein fractions of Dioscorea opposita has opened a separate line of inquiry: previous clinical investigations indicated that Dioscorea extract was effective in mitigating menopausal syndrome by elevating serum estrogen levels. Therefore, the estrogenic ability exhibited by Dioscorea tubers needs to be identified and further investigated to uncover the mechanisms involved. A novel protein fraction designated DOI, isolated from D. opposita, was found to exhibit estrogenic activity in vitro and is under early investigation.

5.2 Blood Glucose Regulation and Diabetes

Evidence level: Promising but predominantly preclinical (animal/in vitro); limited human data.

Dioscorea has great medicinal and therapeutic capabilities and is a potential source of bioactive substances for the prevention and treatment of many diseases. In recent years, increasing attention has been paid to phytochemicals of Dioscorea, such as steroidal saponins, polyphenols, allantoin, and, in particular, polysaccharides and diosgenin.

A systematic review of the glycaemic effects of Dioscorea consumption found: significant changes in body weight and adiposity were observed in nine studies, including improvements in lipid biomarkers in four and reductions in inflammatory markers in one. The current work indicates that the consumption of yam or its extracts can be beneficial for improving blood glucose; however, the molecular mechanism for these effects remains largely unknown. Future trials on human subjects are warranted.

Key findings from pharmacological reviews include: yam polysaccharides demonstrate anti-inflammatory, antioxidant, and immunomodulatory properties; yam glycoprotein shows significant immunomodulatory effects; aqueous extracts can protect against ethanol-induced gastric injury; and an acidic polysaccharide (CYPB) may improve type 2 diabetes by regulating the PI3K/Akt signaling pathway in animal models. One animal study found that yam extract and its active compound allantoin significantly reduced blood glucose levels, improved insulin resistance, and protected pancreatic beta cells in diabetic rats. Allantoin was identified as a key active compound responsible for the antidiabetic effects through inhibition of alpha-amylase and alpha-glucosidase activity.

Studies have shown that allantoin derived from Dioscorea batatas significantly reduced body weight and plasma biochemical parameters, and inhibited structural damage to the liver, pancreas, and skeletal muscle in mice with high-fat-diet (HFD)- and streptozotocin (STZ)-induced diabetes. Allantoin from yam also decreased plasma glucose in diabetic rats in separate animal studies. Mechanistically, mechanisms attributed to diosgenin in ameliorating experimentally induced diabetes include restoration of pancreatic β-cells and down-regulation of enzymes involved in hepatic gluconeogenesis and glucose export.

5.3 Cardiovascular and Lipid Effects

Evidence level: Preclinical only; no controlled human trials identified.

Numerous studies have shown that diosgenin, dioscin, tomatidine, Dioscorea nipponica Makino, and Sanyaku containing diosgenin can induce reductions in total serum cholesterol (TC), very-low-density lipoprotein cholesterol (VLDL-C), LDL-C, and TG, and promote HDL-C levels in rats and mice. Isolated diosgenin decreased total cholesterol and increased high-density lipoprotein in rats in animal experiments. Dyslipidemia involves an imbalance of plasma lipids that may lead to obesity, diabetes, and cardiovascular disease. A study showed that resistant starch (RS) from purple yam (Dioscorea alata L.) reduced body weight, liver weight, and adipose tissue weight in hyperlipidemia-induced hamsters. These findings are all preclinical; controlled human trials on cardiovascular endpoints are lacking as of the available literature.

5.4 Anti-inflammatory and Analgesic Effects

Evidence level: Animal and in vitro; no controlled human trials identified.

A bioassay-guided toxicity and pharmacology study in rodents investigated the anti-inflammatory and antinociceptive properties of D. villosa: both antinociceptive and anti-inflammatory activities were evaluated in experimental models by assessing the toxic effects of the acute (single dose) and subchronic (30 days) oral administration of dry extract of Dioscorea villosa in rodents. The antinociceptive study of D. villosa was performed using models of acetic acid-induced writhing and formalin-induced pain in mice. The anti-inflammatory study was accomplished by leukocyte migration to the peritoneal cavity.

Diosgenin has been found in lab research to help inhibit excessive proliferation and inflammatory response of synovial fibroblasts associated with rheumatoid arthritis. Bioactive compounds possess anti-inflammatory activity and are protective against a variety of inflammatory diseases, such as enteritis, arthritis, dermatitis, acute pancreatitis, and neuroinflammation. Human clinical trials in these areas are absent from the peer-reviewed record.

5.5 Oncology — In Vitro and Preclinical Evidence

Evidence level: In vitro and early preclinical only; no human evidence.

Wild yam extract (Dioscorea villosa, WYE) is consistently lethal at low IC50s across diverse cancer-lines in vitro. Unlike traditional anti-cancer botanicals, WYE contains detergent saponins which reduce oil-water interfacial tensions causing disintegration of lipid membranes and causing cell lysis. WYE caused 346 differentially expressed genes (DEGs) out of 48,226 transcripts tested, where up-regulated DEGs reflect immune stimulation, TNF signaling, COX2, cytokine release, and cholesterol/steroid biosynthesis. WYE was able to halt cell division effectively at low concentrations (15 μg/ml). Research has included integration of diosgenin, as well as other interesting potential drugs, into nanoparticles in order to drive diosgenin to its site of action. Diosgenin functionalized iron oxide nanoparticles, as well as hollow manganese ferrite nanocarriers encapsulating tamoxifen and diosgenin, were developed as potential therapeutic tools against breast cancer. None of these approaches have yet reached human clinical trial stage in the literature available.

5.6 Immunomodulation

Evidence level: Animal/in vitro; no human trials identified.

Dioscorin protein from the tuber of D. alata and Dioscorea japonica showed immune-stimulatory effects in mice. Bioactive compounds possess anti-inflammatory activity and are protective against a variety of inflammatory diseases. In addition, they play an important role in the prevention and treatment of metabolic diseases including obesity, dyslipidemia, diabetes, and non-alcoholic fatty liver disease.

5.7 Bone and Neuroprotective Effects

Evidence level: Animal/in vitro only.

Recent studies indicated that diosgenin may protect against bone loss, namely in experimental models of senescence, menopause, and retinoic acid-induced osteoporosis. Diosgenin has also been shown to treat cardiovascular diseases such as type 2 diabetes and neurodegenerative diseases in preclinical studies. Studies have shown that diosgenin can reduce cognitive impairment, aortic vascular dysfunction, and kidney damage in streptozotocin-induced diabetic rats.

6. Body Systems and Health Areas

Bioactive compounds in Dioscorea are protective against a variety of inflammatory diseases such as enteritis, arthritis, dermatitis, acute pancreatitis, and neuroinflammation. In addition, they play an important role in the prevention and treatment of metabolic diseases including obesity, dyslipidemia, diabetes, and non-alcoholic fatty liver disease.

• Endocrine/Reproductive system: Historically and commercially associated with hormonal support, particularly for menopausal symptoms and dysmenorrhea. Dioscorea contains diosgenin compounds that are used to produce a variety of modern steroid drugs, as well as hormone-related drugs used as contraceptives and to treat menopause and PMS. Clinical evidence for direct hormonal effects in humans is, however, lacking (see Section 5.1).
• Gastrointestinal system: Antispasmodic use in traditional medicine. Wild yam was prescribed for biliary colic and spasm of the bowel in 19th-century Eclectic practice.
• Metabolic/Endocrine system: Experimental studies using yam on health have frequently attested that this crop or its bioactive compounds can act against microbial infections, cardiac damage, hyperglycemia, and high-grade inflammatory conditions.
• Musculoskeletal system: Traditional use for rheumatism and joint pain. Wild yam contains anti-inflammatory compounds that may help reduce symptoms of rheumatoid arthritis (RA), such as joint pain and swelling.
• Cardiovascular system: Preclinical lipid-modulating and anti-atherosclerotic effects documented in animal models.
• Nervous system: Preclinical neuroprotective effects of diosgenin in dementia and diabetic neurological models.
• Immune system: Dioscorin's TLR4 activation and immunomodulatory properties documented in animal and cell studies.

7. Dosage Forms and Dosages Reported in Studies

There are inadequate clinical trials on which to base firm dosing guidelines for medicinal use of Dioscorea.

The following dosage ranges have been reported in the clinical and preclinical literature:

• Studies reported use of wild yam for durations from 4 weeks to 12 months and at dosages from 24 to 2,000 mg/day. They also included formulations ranging from ingested tablets to topically applied creams.
• In a clinical study, 24 apparently healthy postmenopausal women replaced their staple food (rice) with 390 g of yam (Dioscorea alata) in two of three meals per day for 30 days. Fasting blood and first morning urine samples were collected for analyses of blood lipids, sex hormones, urinary estrogen metabolites, and oxidant stress biomarker.
• In the key menopause double-blind crossover trial, wild yam cream was applied topically in 23 women for 3 months each arm.
• In the rodent toxicity study, antinociceptive doses of D. villosa were tested at: morphine (3 mg/kg, i.p.) and DV at 100, 200, and 400 mg/kg per os in mice.
• For the TCM application of D. oppositifolia in diabetes, traditional texts have cited: for diabetes (Lung, stomach, kidney Qi deficiency or Qi and Yin deficiency): up to 250 g per day, decocted and taken as a tea. This reflects traditional dietary/food-level use, not a pharmaceutical dose.
• For cosmetic formulations: industry reported uses in body and hand creams, lotions, powders, and sprays at a concentration of 0.00001%, and in moisturizing creams, lotions, powders, and sprays at concentrations up to 15%.

8. Safety Considerations

General Safety Profile

Few adverse events (if any) have been reported in clinical trials on D. villosa, D. alata, D. batatas, and some combination therapies with unspecified Dioscorea species. A placebo-controlled, randomized, double-blind, cross-over study was conducted on 23 healthy women suffering from symptoms of menopause. All candidates were treated with wild yam cream or placebo for up to three months, and no significant adverse effects were observed in both the treatments.

A clinical study evaluating the daily consumption of wild yam reported no adverse events. Topical preparations of wild yam extract are relatively free from adverse effects.

Preclinical Toxicological Findings

The formal safety assessment by the Cosmetic Ingredient Review (CIR) found: an acute oral toxicity test produced hypoactivity, piloerection, and dyspnea and a death in 1 of 10 rats at 2 g/kg using the specified extract, but no toxicity in rats given 0.5 g/kg. A dermal toxicity test using the specified extract demonstrated no acute toxicity in rats. Both a 7-day local tolerance test and a 28-day dermal toxicity test in rats produced no significant adverse effects at the maximum tested concentration of 10%.

A subchronic rodent study found signals of potential hepatic concern: in the subchronic assay, increased biochemical levels of ALP and direct bilirubin in treated rats (male and female) may be suggestive of cholestatic alterations secondary to changes in biliary flow. Increased levels of AST and ALT, suggesting possible damage to the hepatocytes, were only observed in treated females. However, the treated rats (both males and females) appeared to sustain normal liver function, as there was no reduction in the production of protein or albumin. The values of urea and creatinine were not increased in the blood, indicating that renal function was not affected.

A separate preclinical 28-day study found renal changes: there was no acute reno- or hepato-toxicity associated with administration of D. villosa. However, there was an increase in fibrosis in the kidneys and in inflammation in livers of rats consuming D. villosa for 28 days. Long-term supplementation with D. villosa may be best avoided, especially in people with compromised renal function and in those who need to take other drugs which may alter kidney function.

Species-Specific Toxicity

Kidney and liver damage by D. bulbifera is reported by several researchers. The increasing demand of D. bulbifera, mostly the tuber, as well as illegal/unsustainable harvesting has brought this valuable species to the threatened category. It should be noted that D. bulbifera has a distinct phytochemical profile compared to D. villosa and is generally regarded as more hepatotoxic.

Hormone-Sensitive Conditions

Wild yam is sometimes marketed as a natural source of progesterone. This is because it contains diosgenin, a chemical that can be turned into other hormones, such as progesterone, in a lab. But the human body is not able to convert diosgenin into progesterone. Wild yam is not expected to have any progesterone-like effects in the body, and it is not expected to help with menopause symptoms. Despite this, products marketed as wild yam progesterone cream may have been adulterated with actual progesterone or other hormones, and this cannot be assumed to be absent in unregulated preparations.

Pregnancy and Lactation

Information regarding safety and efficacy in pregnancy and lactation is lacking. Traditional use does include application during pregnancy (for nausea and labor pain), but without modern safety studies this application cannot be clinically endorsed based on available evidence.

Drug Interactions

No well-documented drug interactions have been identified for Dioscorea villosa specifically. However, given diosgenin's activity at the estrogen receptor cascade and PPARγ transcriptional factor, theoretical interactions with hormone therapies, oral contraceptives, and insulin sensitizers are biologically plausible, even if not documented in controlled studies. Though case reports cannot draw a clear line of causation between Dioscorea and adverse events, findings suggest caution might be warranted in medicinal use.

Quality and Standardization Concerns

There are an estimated 600 species of yam in the genus Dioscorea, many of them wild species that flourish in damp woodlands and thickets, and not all contain diosgenin. Misidentification across species is a documented problem. Additionally, there is a very limited market for farmed D. villosa, meaning that almost all of the product on the market is gathered in the wild. This increasing market can put a serious strain on established populations and prevent new colonies from establishing.

9. Overall Evidence Summary

There appears to be strong preclinical-based evidence for most of the benefits listed, but the clinical data appear to be not robust and need stronger evidence by conducting well-controlled clinical trials, as performed for human pharmaceuticals.

The pharmacological potential of diosgenin and other Dioscorea constituents is substantial in laboratory and animal settings, encompassing anti-inflammatory, antidiabetic, cardiovascular-protective, neuroprotective, and potential anticancer activities. These mechanistic studies provide a basis for further development of this compound for pharmacotherapy of various diseases. However, the translation of these findings to validated human clinical outcomes remains largely incomplete. For the most commercially promoted use — menopausal symptom relief — the available controlled evidence is negative. For metabolic indications (blood glucose, dyslipidemia), the systematic review evidence is encouraging in animals but prospective human RCTs are lacking. The current work indicates that consumption of yam or its extracts can be beneficial for improving blood glucose; however, the molecular mechanism for these effects remains largely unknown, and future trials on human subjects are warranted.

References

• Comparative analysis of diosgenin in Dioscorea species and related medicinal plants by UPLC-DAD-MS — PMC
• Diarylheptanoids from Dioscorea villosa (Wild Yam) — PMC / J Nat Prod
• Advances in the pharmacological activities and mechanisms of diosgenin — PubMed (2015)
• Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives — PMC
• Diosgenin: Recent Highlights on Pharmacology and Analytical Methodology — PMC / Journal of Analytical Methods in Chemistry
• Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women — PubMed (Climacteric, 2001)
• A Novel, Stable, Estradiol-Stimulating, Osteogenic Yam Protein — PMC / Scientific Reports (2015)
• Final report of the amended safety assessment of Dioscorea Villosa (Wild Yam) root extract — PubMed / Int J Toxicol (2004)
• Bioassay-guided evaluation of Dioscorea villosa – acute and subchronic toxicity, antinociceptive and anti-inflammatory approach — BMC Complementary Medicine and Therapies (2013)
• Bioassay-guided evaluation of Dioscorea villosa — PMC (2013)
• Dioscorea spp.: Bioactive Compounds and Potential for the Treatment of Inflammatory and Metabolic Diseases — PMC
• Could consumption of yam (Dioscorea) or its extract be beneficial in controlling glycaemia: a systematic review — PMC
• Diosgenin and Its Analogs: Potential Protective Agents Against Atherosclerosis — PMC
• Effects of Wild Yam Root (Dioscorea villosa) Extract on Gene Expression Profile of Triple-negative Breast Cancer Cells — PMC
• Diosgenin protects retinal pigment epithelial cells from inflammatory damage via AMPK/Nrf2/HO-1 pathway — PMC
• Diosgenin alleviates inflammatory damage and insulin resistance in high glucose-induced podocyte cells via AMPK/SIRT1/NF-κB signaling pathway — PMC
• Potential of Neglected and Underutilized Yams (Dioscorea spp.) for Improving Nutritional Security and Health Benefits — Frontiers in Pharmacology (2020)
• Dioscorea spp. (A Wild Edible Tuber): Ethnopharmacological Potential and Traditional Use, Similipal Biosphere Reserve, India — Frontiers in Pharmacology (2017)
• Dioscorea spp. Ethnopharmacological Potential — PMC (2017)
• The genus Dioscorea L. (Dioscoreaceae), a review of traditional uses, phytochemistry, pharmacology, and toxicity — ScienceDirect (2024)
• Dioscorea bulbifera L. (Dioscoreaceae): A review of its ethnobotany, pharmacology and conservation needs — ScienceDirect (2020)
• A systematic review on ethnobotany, phytochemistry and pharmacology of Dioscorea bulbifera L. — ScienceDirect (2024)
• An Update on the Nutritional and Therapeutic Potential of Dioscorea oppositifolia — PMC
• Yam as functional food: bioactive properties, health benefits, and applications — Springer Food, Nutrition and Health (2025)
• The traditional use of the species of the genus Dioscorea — ResearchGate / Journal of Ethnopharmacology
• Wild Yam — Memorial Sloan Kettering Cancer Center Herb Monograph
• Wild Yam Uses, Benefits & Dosage — Drugs.com Natural Products Database (reviewed 2025)
• What are wild yam's main drawbacks? — Examine.com
• Safety Assessment of Dioscorea Villosa (Wild Yam) Root Extract — Cosmetic Ingredient Review (CIR, 2023)
• Wild Yam – Dioscorea villosa — United Plant Savers
• Fenugreek derived diosgenin as an emerging source for diabetic therapy — Frontiers in Nutrition (2024)